World's Best Scientists 2026 revealed!
Robert Ian Nicholson

Robert Ian Nicholson

D-Index & Metrics

Medicine

D-Index
102
Citations
35827
World Ranking
7707
National Ranking
756

Overview

Robert Ian Nicholson is affiliated with Cardiff University in the United Kingdom. Their research is focused within the broad field of Medicine, with a specific subfield concentration on Obstetrics and Gynecology.

Their academic output includes recent work published in specialized journals related to minimally invasive procedures in gynecology. The recent paper authored by Nicholson is titled To Void or Not to Void After Minimally Invasive Benign Hysterectomy: That Is the Question, published in 2024 in the Journal of Minimally Invasive Gynecology.

Their work principally revolves around the topic of uterine myomas and treatments concerning this condition, as reflected in the themes addressed by their research publications.

Frequent coauthors collaborating with Nicholson include:

  • Michel Leneveu
  • Janet L. Davis
  • MC Leaf
  • Kristin E. Musselman
  • Karen H Simpson

The primary publication venue where Nicholson's work appears is the Journal of Minimally Invasive Gynecology, which aligns with their focus on minimally invasive surgical techniques in gynecological practice.

Best Publications

  • EGFR and cancer prognosis

    Robert Ian Nicholson;Julia Margaret Wendy Gee;Maureen Elaine Harper

  • Expression and amplification of cyclin genes in human breast cancer.

    M. F. Buckley;K. J. E. Sweeney;J. A. Hamilton;R. L. Sini

  • A prognostic index in primary breast cancer.

    J L Haybittle;R W Blamey;C W Elston;J Johnson

  • Expression of luminal and basal cytokeratins in human breast carcinoma

    Dalia M Abd El-Rehim;Sarah E Pinder;Claire E Paish;J Bell

  • Elevated Levels of Epidermal Growth Factor Receptor/c-erbB2 Heterodimers Mediate an Autocrine Growth Regulatory Pathway in Tamoxifen-Resistant MCF-7 Cells

    Janice Mary Knowlden;Iain Robert Hutcheson;Helen E. Jones;Tracie-Ann Madden

  • Pharmacodynamic Studies of the Epidermal Growth Factor Receptor Inhibitor ZD1839 in Skin From Cancer Patients: Histopathologic and Molecular Consequences of Receptor Inhibition

    Joan Albanell;Federico Rojo;Steve Averbuch;Andrea Feyereislova

  • Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action.

    C K Osborne;A E Wakeling;R I Nicholson

  • Phosphorylated Insulin-Like Growth Factor-I/Insulin Receptor Is Present in All Breast Cancer Subtypes and Is Related to Poor Survival

    Jennifer H. Law;Golareh Habibi;Kaiji Hu;Hamid Masoudi

  • Comparison of the Effects of a Pure Steroidal antiestrogen With Those of Tamoxifen in a Model of Human Breast Cancer

    Osborne Ck;Coronado-Heinsohn Eb;Hilsenbeck Sg;McCue Bl

  • New Arylthioindoles: Potent Inhibitors of Tubulin Polymerization. 2. Structure−Activity Relationships and Molecular Modeling Studies

    Gabriella De Martino;Michael C. Edler;Giuseppe La Regina;Antonio Coluccia

  • Regulation of ERBB2 by oestrogen receptor–PAX2 determines response to tamoxifen

    Antoni Hurtado;Kelly A. Holmes;Timothy R. Geistlinger;Iain Robert Hutcheson

  • Biologic and Clinical Characteristics of Breast Cancer With Single Hormone Receptor–Positive Phenotype

    Emad A. Rakha;Maysa E. El-Sayed;Andrew R. Green;E. Claire Paish

  • Insulin-like growth factor-I receptor signalling and acquired resistance to gefitinib (ZD1839; Iressa) in human breast and prostate cancer cells

    Helen E. Jones;Lindy Goddard;Julia Margaret Wendy Gee;Stephen Edward Hiscox

  • Investigation of a New Pure Antiestrogen (ICI 182780) in Women with Primary Breast Cancer

    David J DeFriend;Anthony Howell;R I Nicholson;Elizabeth Anderson

  • Epidermal growth factor receptor/HER2/insulin-like growth factor receptor signalling and oestrogen receptor activity in clinical breast cancer

    Julia Margaret Wendy Gee;J. F. Robertson;E. Gutteridge;I. O. Ellis

  • Enhanced epidermal growth factor receptor signaling in MCF7 breast cancer cells after long-term culture in the presence of the pure antiestrogen ICI 182,780 (Faslodex).

    Richard Andrew McClelland;Denise Barrow;Tracie-Ann Madden;Carol Mary Dutkowski

  • Ki67 immunostaining in primary breast cancer: pathological and clinical associations.

    N. Bouzubar;K. J. Walker;K. Griffiths;I. O. Ellis

  • Activated Extracellular Signal-regulated Kinases: Association with Epidermal Growth Factor Receptor/Transforming Growth Factor α Expression in Head and Neck Squamous Carcinoma and Inhibition by Anti-Epidermal Growth Factor Receptor Treatments

    Joan Albanell;Jordi Codony-Servat;Federico Rojo;José M. Del Campo

  • Phosphorylation of ERK1/2 mitogen-activated protein kinase is associated with poor response to anti-hormonal therapy and decreased patient survival in clinical breast cancer.

    Julia M.W. Gee;John F.R. Robertson;Ian O. Ellis;Robert I. Nicholson

  • Immunohistochemical determination of estrogen receptor-alpha phosphorylation in activation function AF1 in primary and tamoxifen-resistant breast cancer is indicative of a complex role for estrogen receptor-alpha phosphorylation in breast cancer progression [Abstract]

    S. Ali;N. Sarwar;J. Jiang;D. Peston

Frequent Co-Authors

Julia Margaret Wendy Gee
Julia Margaret Wendy Gee Cardiff University
Roger W. Blamey
Roger W. Blamey Nottingham City Hospital
John F.R. Robertson
John F.R. Robertson University of Nottingham
Ian O. Ellis
Ian O. Ellis University of Nottingham
Elizabeth A. Musgrove
Elizabeth A. Musgrove University of Glasgow
C.W. Elston
C.W. Elston University of Nottingham
Sarah E Pinder
Sarah E Pinder King's College London
Peter Davies
Peter Davies University of Queensland
Anthony Howell
Anthony Howell University of Manchester
Mitch Dowsett
Mitch Dowsett Breast Cancer Research Foundation

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine or healthcare doesn't always follow a single path. There are now more flexible options, with many students choosing online programs to fit their schedules and goals. For registered nurses considering advancement, adn to fnp bridge programs allow you to move from an associate’s to a master’s degree and become a Family Nurse Practitioner faster.

Other healthcare fields are also rapidly expanding. Those interested in diet and health can explore the best online nutrition degree options, preparing graduates for careers in wellness, sports medicine, or clinical nutrition.

Leadership roles in healthcare, such as administration or management, often require specialized education. Choosing cahme-accredited online Master of Healthcare Administration (MHA) programs ensures rigorous training recognized across the industry.

Lastly, for RNs looking to upgrade their qualifications quickly, rn to bsn online no clinicals accredited programs provide an efficient and accessible way to earn a bachelor’s degree—often with maximum flexibility and minimal on-site requirements.

Best Scientists Citing Robert Ian Nicholson

Trending Scientists

Recently Published Articles